Timolol Maleate Drug Combination Brimonidine Tartrate

A pharmaceutical preparation of brimonidine tartrate and timolol maleate. The combined ADRENERGIC ALPHA2 RECEPTOR AGONIST and ADRENERGIC BETA-ANTAGONIST activity of these drugs reduce INTRAOCULAR PRESSURE in GLAUCOMA patients.

Also Known As:

Brimonidine Tartrate, Timolol Maleate Drug Combination; Brimonidine Tartrate-Timolol Maleate; Brimonidine Tartrate-Timolol Maleate Drug Combination; Combigan; Brimonidine Tartrate Timolol Maleate; Brimonidine Tartrate Timolol Maleate Drug Combination; Maleate, Brimonidine Tartrate-Timolol; Tartrate-Timolol Maleate, Brimonidine

Networked: 10 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Drug Context: Research Results

Experts

1.	Kim, Joon Mo: 1 article (03/2021)
2.	Lee, Ji Woong: 1 article (03/2021)
3.	Maglambayan, Joy: 1 article (03/2021)
4.	Park, Ki Ho: 1 article (03/2021)
5.	Park, Sang Woo: 1 article (03/2021)
6.	Simonyi, Susan: 1 article (03/2021)
7.	Bayart, Cheryl: 1 article (07/2016)
8.	Desai, Ritu: 1 article (07/2016)
9.	Gill, Kamalvir: 1 article (07/2016)
10.	Golden, Alex: 1 article (07/2016)

Related Diseases

1.	Ocular Hypertension (Glaucoma, Suspect) 02/01/2011 - "This study was undertaken to compare the ocular haemodynamic effects of Combigan(®) versus placebo in patients with ocular hypertension (OHT). " 09/01/2014 - "Combination therapy with three antiglaucoma agents in the form of two medications--dorzolamide 2% and brimonidine/timolol fixed combination (Combigan)--is shown to be effective in uveal ocular hypertension patients."
2.	Glaucoma 09/01/2008 - "To evaluate the incidence of ocular allergy in glaucoma patients prospectively treated with 0.2% brimonidine-0.5% timolol fixed combination (Combigan) compared with the incidence of ocular allergy in patients treated with 0.2% brimonidine (Alphagan) monotherapy. " 04/17/2013 - "We report three patients with superficial haemangiomas treated topically with Combigan ophthalmic solution (brimonidine 0.2%-timolol 0.5%), a combination selective α-2-adrenergic agonist and non-selective β-blocker Food and Drug Administration-approved for use in glaucoma. " 01/01/2008 - "Current commercially available fixed combinations used in glaucoma treatment include Combigan, Cosopt, Xalcom, Duotrav and Ganfort. "
3.	Open-Angle Glaucoma (Glaucoma, Open Angle) 03/01/2021 - "Efficacy and safety of fixed-combination brimonidine tartrate/timolol maleate in primary open-angle glaucoma, including normal-tension glaucoma." 07/01/2010 - "To compare brimonidine/timolol fixed combination (BrTFC; Combigan *) with dorzolamide/timolol fixed combination (DTFC; Cosopt dagger) in terms of ability to lower intraocular pressure (IOP) in primary open-angle glaucoma (POAG). "
4.	Low Tension Glaucoma 03/01/2021 - "Efficacy and safety of fixed-combination brimonidine tartrate/timolol maleate in primary open-angle glaucoma, including normal-tension glaucoma."
5.	Macular Degeneration (Age-Related Maculopathy) 04/01/2010 - "One eye of 88 consecutive normotensive age-related macular degeneration patients receiving Lucentis was randomized into placebo drops (artificial tears, 44 patients) or Combigan drops (44 patients) given twice a day the day before and the day of injection. "

Related Drugs and Biologics

1.	Timolol (Blocadren)
2.	Brimonidine Tartrate (Alphagan)
3.	dorzolamide (Trusopt)
4.	Antiglaucoma Agents
5.	dorzolamide-timolol combination (Cosopt)
6.	Lubricant Eye Drops (Artificial Tears)
7.	Dexrazoxane (Zinecard)
8.	Ghrelin
9.	Interleukin 1 Receptor Antagonist Protein (Anakinra)
10.	Teriparatide (Parathar)

Related Therapies and Procedures

1.	Therapeutics